Dantrium Intravenous and Lorcaserin Extended-Release Tablets
Determining the interaction of Dantrium Intravenous and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dantrolene
Brand name: Dantrium, Dantrium Intravenous, Revonto, Ryanodex
Synonyms: n.a.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dantrium Intravenous-Lorcaserin Hydrochloride
- Dantrium Intravenous-Lorcaserin Tablets
- Dantrium Intravenous-Lorcet
- Dantrium Intravenous-Lorcet Plus
- Dantrium Intravenous-Lorcet Tablets
- Dantrium Intravenous-Lorlatinib
- Lorcaserin Extended-Release Tablets-Dantrolene
- Lorcaserin Extended-Release Tablets-Dantrolene Capsules
- Lorcaserin Extended-Release Tablets-Dantrolene Injection
- Lorcaserin Extended-Release Tablets-Dantrolene Intravenous
- Lorcaserin Extended-Release Tablets-Dantrolene Sodium
- Lorcaserin Extended-Release Tablets-Dapagliflozin